Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 August 1998 | Volume 129 Issue 4 | Pages 299-302
Background: Despite the widespread use of subcutaneous heparin in the initial treatment of deep venous thrombosis, there are no guidelines for achieving adequate anticoagulation with this drug.
Objective: To implement a weight-based algorithm for the administration of subcutaneous unfractionated heparin after an intravenous loading dose.
Design: Prospective cohort study.
Setting: University hospital.
Participants: 70 outpatients with proximal venous thrombosis.
Intervention: An intravenous bolus of heparin followed by a subcutaneous injection of heparin in doses adjusted for body weight. Subsequent adjustments of the subcutaneous heparin dose were scheduled twice daily according to the algorithm; the activated partial thromboplastin time (aPT) was measured in the mid-interval (target range, 50 to 90 seconds).
Results: The therapeutic threshold aPT (
Conclusion: The administration of subcutaneous heparin according to a weight-based algorithm allows the rapid achievement of effective and safe anticoagulation in patients with deep venous thrombosis.
Author and Article Information
From the University of Padua Medical School, Padua, Italy
BRIEF COMMUNICATION
Use of an Algorithm for Administering Subcutaneous Heparin in the Treatment of Deep Venous Thrombosis
50 seconds) was achieved in 61 patients (87%) within 24 hours and in 69 patients (99%) within 48 hours. In 7 patients (10%), a supratherapeutic aPT lasted more than 12 hours. No major bleeding episodes or cases of heparin-induced thrombocytopenia were seen. Three patients (4.3% [95% CI, 0.9% to 12.0%]) had recurrent thromboembolism during 3 months of follow-up.
![]()
Requests for Reprints: Paolo Prandoni, MD, PhD, Institute of Medical Semeiotics, University of Padua Medical School, via Ospedale Civile, 105, 35128 Padua, Italy.
Current Author Addresses: Drs. Prandoni, Bagatella, Bernardi, B. Girolami, Rossi, Scarano, Marchiori, Piccioli, and A. Girolami: Institute of Medical Semeiotics, University of Padua Medical School, via Ospedale Civile, 105, 35128 Padua, Italy.
Related articles in Annals:
This article has been cited by other articles:
![]() |
P. Prandoni How I treat venous thromboembolism in patients with cancer Blood, December 15, 2005; 106(13): 4027 - 4033. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee for the Galilei Investigators Subcutaneous Adjusted-Dose Unfractionated Heparin vs Fixed-Dose Low-Molecular-Weight Heparin in the Initial Treatment of Venous Thromboembolism Arch Intern Med, May 24, 2004; 164(10): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. J. van Dongen, R. Vink, B. A. Hutten, H. R. Buller, and M. H. Prins The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis Arch Intern Med, June 9, 2003; 163(11): 1285 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alatri, P. Bucciarelli, and M. Moia Subcutaneous Heparin for Deep Venous Thrombosis Ann Intern Med, June 15, 1999; 130(12): 1027 - 1027. [Full Text] [PDF] |
||||